Determinants at the N- and C-termini of Gα12 required for activation of Rho-mediated signaling

Heterotrimeric guanine nucleotide binding proteins of the G12/13 subfamily, which includes the α-subunits Gα12 and Gα13, stimulate the monomeric G protein RhoA through interaction with a distinct subset of Rho-specific guanine nucleotide exchange factors (RhoGEFs). The structural features that media...

Full description

Saved in:
Bibliographic Details
Published inJournal of molecular signaling Vol. 8; no. 1; p. 3
Main Authors Ritchie, Benjamin J, Smolski, William C, Montgomery, Ellyn R, Fisher, Elizabeth S, Choi, Tina Y, Olson, Calla M, Foster, Lori A, Meigs, Thomas E
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 25.03.2013
BioMed Central
Online AccessGet full text

Cover

Loading…
Abstract Heterotrimeric guanine nucleotide binding proteins of the G12/13 subfamily, which includes the α-subunits Gα12 and Gα13, stimulate the monomeric G protein RhoA through interaction with a distinct subset of Rho-specific guanine nucleotide exchange factors (RhoGEFs). The structural features that mediate interaction between Gα13 and RhoGEFs have been examined in crystallographic studies of the purified complex, whereas a Gα12:RhoGEF complex has not been reported. Several signaling responses and effector interactions appear unique to Gα12 or Gα13, despite their similarity in amino acid sequence. To comprehensively examine Gα12 for regions involved in RhoGEF interaction, we screened a panel of Gα12 cassette substitution mutants for binding to leukemia-associated RhoGEF (LARG) and for activation of serum response element mediated transcription. We identified several cassette substitutions that disrupt Gα12 binding to LARG and the related p115RhoGEF. These Gα12 mutants also were impaired in activating serum response element mediated signaling, a Rho-dependent response. Most of these mutants matched corresponding regions of Gα13 reported to contact p115RhoGEF, but unexpectedly, several RhoGEF-uncoupling mutations were found within the N- and C-terminal regions of Gα12. Trypsin protection assays revealed several mutants in these regions as retaining conformational activation. In addition, charge substitutions near the Gα12 N-terminus selectively disrupted binding to LARG but not p115RhoGEF. Several structural aspects of the Gα12:RhoGEF interface differ from the reported Gα13:RhoGEF complex, particularly determinants within the C-terminal α5 helix and structurally uncharacterized N-terminus of Gα12. Furthermore, key residues at the Gα12 N-terminus may confer selectivity for LARG as a downstream effector.
AbstractList BACKGROUND: Heterotrimeric guanine nucleotide binding proteins of the G12/13 subfamily, which includes the α-subunits Gα12 and Gα13, stimulate the monomeric G protein RhoA through interaction with a distinct subset of Rho-specific guanine nucleotide exchange factors (RhoGEFs). The structural features that mediate interaction between Gα13 and RhoGEFs have been examined in crystallographic studies of the purified complex, whereas a Gα12:RhoGEF complex has not been reported. Several signaling responses and effector interactions appear unique to Gα12 or Gα13, despite their similarity in amino acid sequence. METHODS: To comprehensively examine Gα12 for regions involved in RhoGEF interaction, we screened a panel of Gα12 cassette substitution mutants for binding to leukemia-associated RhoGEF (LARG) and for activation of serum response element mediated transcription. RESULTS: We identified several cassette substitutions that disrupt Gα12 binding to LARG and the related p115RhoGEF. These Gα12 mutants also were impaired in activating serum response element mediated signaling, a Rho-dependent response. Most of these mutants matched corresponding regions of Gα13 reported to contact p115RhoGEF, but unexpectedly, several RhoGEF-uncoupling mutations were found within the N- and C-terminal regions of Gα12. Trypsin protection assays revealed several mutants in these regions as retaining conformational activation. In addition, charge substitutions near the Gα12 N-terminus selectively disrupted binding to LARG but not p115RhoGEF. CONCLUSIONS: Several structural aspects of the Gα12:RhoGEF interface differ from the reported Gα13:RhoGEF complex, particularly determinants within the C-terminal α5 helix and structurally uncharacterized N-terminus of Gα12. Furthermore, key residues at the Gα12 N-terminus may confer selectivity for LARG as a downstream effector.
BACKGROUNDHeterotrimeric guanine nucleotide binding proteins of the G12/13 subfamily, which includes the α-subunits Gα12 and Gα13, stimulate the monomeric G protein RhoA through interaction with a distinct subset of Rho-specific guanine nucleotide exchange factors (RhoGEFs). The structural features that mediate interaction between Gα13 and RhoGEFs have been examined in crystallographic studies of the purified complex, whereas a Gα12:RhoGEF complex has not been reported. Several signaling responses and effector interactions appear unique to Gα12 or Gα13, despite their similarity in amino acid sequence. METHODSTo comprehensively examine Gα12 for regions involved in RhoGEF interaction, we screened a panel of Gα12 cassette substitution mutants for binding to leukemia-associated RhoGEF (LARG) and for activation of serum response element mediated transcription. RESULTSWe identified several cassette substitutions that disrupt Gα12 binding to LARG and the related p115RhoGEF. These Gα12 mutants also were impaired in activating serum response element mediated signaling, a Rho-dependent response. Most of these mutants matched corresponding regions of Gα13 reported to contact p115RhoGEF, but unexpectedly, several RhoGEF-uncoupling mutations were found within the N- and C-terminal regions of Gα12. Trypsin protection assays revealed several mutants in these regions as retaining conformational activation. In addition, charge substitutions near the Gα12 N-terminus selectively disrupted binding to LARG but not p115RhoGEF. CONCLUSIONSSeveral structural aspects of the Gα12:RhoGEF interface differ from the reported Gα13:RhoGEF complex, particularly determinants within the C-terminal α5 helix and structurally uncharacterized N-terminus of Gα12. Furthermore, key residues at the Gα12 N-terminus may confer selectivity for LARG as a downstream effector.
Heterotrimeric guanine nucleotide binding proteins of the G12/13 subfamily, which includes the α-subunits Gα12 and Gα13, stimulate the monomeric G protein RhoA through interaction with a distinct subset of Rho-specific guanine nucleotide exchange factors (RhoGEFs). The structural features that mediate interaction between Gα13 and RhoGEFs have been examined in crystallographic studies of the purified complex, whereas a Gα12:RhoGEF complex has not been reported. Several signaling responses and effector interactions appear unique to Gα12 or Gα13, despite their similarity in amino acid sequence. To comprehensively examine Gα12 for regions involved in RhoGEF interaction, we screened a panel of Gα12 cassette substitution mutants for binding to leukemia-associated RhoGEF (LARG) and for activation of serum response element mediated transcription. We identified several cassette substitutions that disrupt Gα12 binding to LARG and the related p115RhoGEF. These Gα12 mutants also were impaired in activating serum response element mediated signaling, a Rho-dependent response. Most of these mutants matched corresponding regions of Gα13 reported to contact p115RhoGEF, but unexpectedly, several RhoGEF-uncoupling mutations were found within the N- and C-terminal regions of Gα12. Trypsin protection assays revealed several mutants in these regions as retaining conformational activation. In addition, charge substitutions near the Gα12 N-terminus selectively disrupted binding to LARG but not p115RhoGEF. Several structural aspects of the Gα12:RhoGEF interface differ from the reported Gα13:RhoGEF complex, particularly determinants within the C-terminal α5 helix and structurally uncharacterized N-terminus of Gα12. Furthermore, key residues at the Gα12 N-terminus may confer selectivity for LARG as a downstream effector.
Author Fisher, Elizabeth S
Smolski, William C
Olson, Calla M
Foster, Lori A
Meigs, Thomas E
Choi, Tina Y
Montgomery, Ellyn R
Ritchie, Benjamin J
AuthorAffiliation 1 Department of Biology, University of North Carolina at Asheville, One University Heights, Asheville, NC 28804, USA
AuthorAffiliation_xml – name: 1 Department of Biology, University of North Carolina at Asheville, One University Heights, Asheville, NC 28804, USA
Author_xml – sequence: 1
  givenname: Benjamin J
  surname: Ritchie
  fullname: Ritchie, Benjamin J
  email: tmeigs@unca.edu
  organization: Department of Biology, University of North Carolina at Asheville, One University Heights, Asheville, NC 28804, USA. tmeigs@unca.edu
– sequence: 2
  givenname: William C
  surname: Smolski
  fullname: Smolski, William C
– sequence: 3
  givenname: Ellyn R
  surname: Montgomery
  fullname: Montgomery, Ellyn R
– sequence: 4
  givenname: Elizabeth S
  surname: Fisher
  fullname: Fisher, Elizabeth S
– sequence: 5
  givenname: Tina Y
  surname: Choi
  fullname: Choi, Tina Y
– sequence: 6
  givenname: Calla M
  surname: Olson
  fullname: Olson, Calla M
– sequence: 7
  givenname: Lori A
  surname: Foster
  fullname: Foster, Lori A
– sequence: 8
  givenname: Thomas E
  surname: Meigs
  fullname: Meigs, Thomas E
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23531275$$D View this record in MEDLINE/PubMed
BookMark eNp1kctKJDEUhsPgMF7GpVvJ0k00qVQqcSNKewWZAXHW4VTVqe5IVaJJusHH8kV8JrtobZTBVRL-jy_nsk02fPBIyJ7gh0KY6khoxVkhjGaGyR9ka_3e-HTfJNspPXCupCqrX2SzkEqKQqstYs8xYxycB58ThUzzDOkfRsG3dMJWkaOho1evL6KgEZ_mLmJLuxApNNktILvgR-BuFtiArYO8jJObeuidn_4mPzvoE-6-nzvk3-XF_eSa3f69upmc3bJaFjwzVBqhaXnRoEZZY6MrXZXIoQIUbVlyrUGawujW1FIpqLFbIobXppRaqGO5Q05W3sd5vayiQZ8j9PYxugHisw3g7NfEu5mdhoWVlay4HgWnK0HtwjeCr0kTBjsO2I4DtsbKpeLgvYYYnuaYsh1carDvwWOYJytkWSmtj82IshXaxJBSxG79keB23Ot_6v3P7a3pj0XKNzhkoYc
CitedBy_id crossref_primary_10_1074_jbc_RA119_011648
crossref_primary_10_1016_j_bbrc_2016_04_048
crossref_primary_10_1016_j_cellsig_2020_109653
crossref_primary_10_5334_1750_2187_11_3
crossref_primary_10_1016_j_yjmcc_2016_12_008
crossref_primary_10_7554_eLife_60155
crossref_primary_10_1016_j_cellsig_2022_110534
Cites_doi 10.1124/pr.54.3.527
10.1016/j.cellsig.2009.02.010
10.1146/annurev.cellbio.21.020604.150721
10.1074/jbc.C400105200
10.1074/jbc.M108711200
10.1159/000186690
10.1016/j.str.2008.07.009
10.1126/science.280.5372.2112
10.1016/S0960-9822(02)01034-5
10.1016/S0955-0674(96)80065-2
10.1074/jbc.M410594200
10.1083/jcb.200501104
10.1038/334712a0
10.1126/science.275.5299.533
10.1074/jbc.C400508200
10.1128/MCB.21.22.7775-7786.2001
10.1074/jbc.270.4.1734
10.1016/j.tips.2008.08.002
10.1016/j.cellsig.2010.09.005
10.1038/nsmb888
10.1073/pnas.82.16.5255
10.1126/science.280.5372.2109
10.1074/jbc.M301409200
10.1074/jbc.M001863200
10.1021/bi051729t
10.1074/jbc.274.9.5868
10.1124/mol.106.033555
10.1016/S0092-8674(00)80482-1
10.1016/j.cellsig.2007.03.004
10.1016/S0014-5793(00)02224-9
10.1111/j.1476-5381.2009.00180.x
10.1073/pnas.0234057100
10.1073/pnas.0510254103
10.1074/jbc.M110.201392
10.1038/ncb2507
10.1073/pnas.94.19.10098
10.1073/pnas.102291599
10.1074/jbc.M007608200
10.1101/gad.12.1.95
10.1021/bi700235f
10.1073/pnas.2533143100
ContentType Journal Article
Copyright Copyright © 2013 Ritchie et al.; licensee BioMed Central Ltd. 2013 Ritchie et al.; licensee BioMed Central Ltd.
Copyright_xml – notice: Copyright © 2013 Ritchie et al.; licensee BioMed Central Ltd. 2013 Ritchie et al.; licensee BioMed Central Ltd.
DBID NPM
AAYXX
CITATION
7X8
5PM
DOI 10.1186/1750-2187-8-3
DatabaseName PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle PubMed
CrossRef
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
EISSN 1750-2187
EndPage 3
ExternalDocumentID oai_biomedcentral_com_1750_2187_8_3
10_1186_1750_2187_8_3
23531275
Genre Journal Article
GroupedDBID -A0
.0O
29L
2WC
3V.
4.4
5GY
7X7
8FE
8FH
8FI
8FJ
AAFWJ
AAPRH
ABDBF
ABUWG
ACCQO
ACGFO
ACGFS
ACPRK
ADBBV
ADINQ
ADRAZ
ADUKV
AEGXH
AFKRA
AHBYD
AHMBA
AIAGR
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BBNVY
BENPR
BHPHI
BMC
BPHCQ
BVXVI
C6C
CCPQU
CS3
DIK
E3Z
EBD
EBS
EJD
ESX
F5P
FYUFA
GX1
H13
HCIFZ
HMCUK
HYE
IAO
IGS
IHR
ISR
ITC
KQ8
LK8
M48
M7P
M~E
NPM
O5R
O5S
OK1
P2P
PGMZT
PQQKQ
PROAC
RNS
ROL
RPM
RSV
SBL
TR2
TUS
UKHRP
WOQ
~8M
AAYXX
CITATION
7X8
ABVAZ
AFGXO
AFNRJ
5PM
ID FETCH-LOGICAL-b320t-e57eacd02ce7e3bec76764e0a6ae1d44077a38287d8b355abefc7680b84371593
IEDL.DBID RPM
ISSN 1750-2187
IngestDate Tue Sep 17 21:08:46 EDT 2024
Wed May 22 07:14:27 EDT 2024
Fri Oct 25 02:54:53 EDT 2024
Fri Dec 06 04:25:16 EST 2024
Sat Sep 28 07:50:47 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License http://creativecommons.org/licenses/by/4.0
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b320t-e57eacd02ce7e3bec76764e0a6ae1d44077a38287d8b355abefc7680b84371593
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3636079/
PMID 23531275
PQID 1346577983
PQPubID 23479
PageCount 1
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3636079
biomedcentral_primary_oai_biomedcentral_com_1750_2187_8_3
proquest_miscellaneous_1346577983
crossref_primary_10_1186_1750_2187_8_3
pubmed_primary_23531275
PublicationCentury 2000
PublicationDate 2013-Mar-25
2013-03-25
20130325
PublicationDateYYYYMMDD 2013-03-25
PublicationDate_xml – month: 03
  year: 2013
  text: 2013-Mar-25
  day: 25
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Journal of molecular signaling
PublicationTitleAlternate J Mol Signal
PublicationYear 2013
Publisher BioMed Central Ltd
BioMed Central
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
References 9420334 - Genes Dev. 1998 Jan 1;12(1):95-106
19249348 - Cell Signal. 2009 Jun;21(6):996-1006
12515866 - Proc Natl Acad Sci U S A. 2003 Jan 21;100(2):733-8
9428514 - Cell. 1997 Dec 26;91(7):905-15
1556134 - J Biol Chem. 1992 Mar 25;267(9):6272-7
8791425 - Curr Opin Cell Biol. 1996 Apr;8(2):189-96
17854659 - Adv Protein Chem. 2007;74:189-228
10026210 - J Biol Chem. 1999 Feb 26;274(9):5868-79
16212495 - Annu Rev Cell Dev Biol. 2005;21:247-69
7829508 - J Biol Chem. 1995 Jan 27;270(4):1734-41
16705036 - Proc Natl Acad Sci U S A. 2006 May 23;103(21):8173-8
15928205 - J Cell Biol. 2005 Jun 6;169(5):777-87
9641916 - Science. 1998 Jun 26;280(5372):2112-4
8999798 - Science. 1997 Jan 24;275(5299):533-6
9294169 - Proc Natl Acad Sci U S A. 1997 Sep 16;94(19):10098-103
9641915 - Science. 1998 Jun 26;280(5372):2109-11
19212140 - Neurosignals. 2009;17(1):55-70
11094164 - FEBS Lett. 2000 Nov 24;485(2-3):183-8
3137475 - Nature. 1988 Aug 25;334(6184):712-5
21507947 - J Biol Chem. 2011 Jun 10;286(23):20625-36
12077299 - Proc Natl Acad Sci U S A. 2002 Jul 9;99(14):9352-7
2410917 - Proc Natl Acad Sci U S A. 1985 Aug;82(16):5255-9
14657363 - Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):14748-53
15143072 - J Biol Chem. 2004 Jul 9;279(28):28831-4
12594220 - J Biol Chem. 2003 Apr 25;278(17):14936-9
11136230 - Proc Natl Acad Sci U S A. 2001 Jan 16;98(2):519-24
17503779 - Biochemistry. 2007 Jun 12;46(23):6677-87
20837139 - Cell Signal. 2011 Jan;23(1):213-21
17449226 - Cell Signal. 2007 Aug;19(8):1681-9
15665872 - Nat Struct Mol Biol. 2005 Feb;12(2):191-7
15746095 - J Biol Chem. 2005 May 6;280(18):18049-55
10816569 - J Biol Chem. 2000 Aug 25;275(34):26206-12
22609986 - Nat Cell Biol. 2012 May 20;14 (7):686-96
15951850 - Int J Biol Sci. 2005;1(2):51-66
12176367 - Curr Biol. 2002 Aug 6;12(15):1353-8
12223533 - Pharmacol Rev. 2002 Sep;54(3):527-59
18814923 - Trends Pharmacol Sci. 2008 Nov;29(11):582-9
15485891 - J Biol Chem. 2004 Dec 24;279(52):54283-90
11598136 - J Biol Chem. 2001 Dec 7;276(49):46088-93
18940608 - Structure. 2008 Oct 8;16(10):1532-43
19422395 - Br J Pharmacol. 2009 Sep;158(1):32-40
15525651 - J Biol Chem. 2004 Dec 31;279(53):54983-6
16388592 - Biochemistry. 2006 Jan 10;45(1):167-74
11076942 - J Biol Chem. 2001 Feb 9;276(6):4227-35
17303700 - Mol Pharmacol. 2007 May;71(5):1268-76
11604512 - Mol Cell Biol. 2001 Nov;21(22):7775-86
10.1186/1750-2187-8-3-B18
10.1186/1750-2187-8-3-B17
10.1186/1750-2187-8-3-B39
10.1186/1750-2187-8-3-B19
10.1186/1750-2187-8-3-B14
10.1186/1750-2187-8-3-B36
10.1186/1750-2187-8-3-B13
10.1186/1750-2187-8-3-B35
10.1186/1750-2187-8-3-B16
10.1186/1750-2187-8-3-B38
10.1186/1750-2187-8-3-B37
10.1186/1750-2187-8-3-B10
10.1186/1750-2187-8-3-B32
10.1186/1750-2187-8-3-B12
10.1186/1750-2187-8-3-B11
10.1186/1750-2187-8-3-B33
10.1186/1750-2187-8-3-B30
10.1186/1750-2187-8-3-B29
10.1186/1750-2187-8-3-B28
10.1186/1750-2187-8-3-B8
10.1186/1750-2187-8-3-B25
10.1186/1750-2187-8-3-B9
10.1186/1750-2187-8-3-B24
10.1186/1750-2187-8-3-B46
10.1186/1750-2187-8-3-B6
10.1186/1750-2187-8-3-B27
10.1186/1750-2187-8-3-B7
10.1186/1750-2187-8-3-B26
10.1186/1750-2187-8-3-B5
10.1186/1750-2187-8-3-B2
10.1186/1750-2187-8-3-B3
10.1186/1750-2187-8-3-B1
10.1186/1750-2187-8-3-B21
10.1186/1750-2187-8-3-B43
10.1186/1750-2187-8-3-B20
10.1186/1750-2187-8-3-B42
10.1186/1750-2187-8-3-B23
10.1186/1750-2187-8-3-B45
10.1186/1750-2187-8-3-B22
10.1186/1750-2187-8-3-B41
10.1186/1750-2187-8-3-B40
References_xml – ident: 10.1186/1750-2187-8-3-B14
  doi: 10.1124/pr.54.3.527
– ident: 10.1186/1750-2187-8-3-B37
  doi: 10.1016/j.cellsig.2009.02.010
– ident: 10.1186/1750-2187-8-3-B5
  doi: 10.1146/annurev.cellbio.21.020604.150721
– ident: 10.1186/1750-2187-8-3-B18
  doi: 10.1074/jbc.C400105200
– ident: 10.1186/1750-2187-8-3-B33
  doi: 10.1074/jbc.M108711200
– ident: 10.1186/1750-2187-8-3-B2
  doi: 10.1159/000186690
– ident: 10.1186/1750-2187-8-3-B16
  doi: 10.1016/j.str.2008.07.009
– ident: 10.1186/1750-2187-8-3-B10
  doi: 10.1126/science.280.5372.2112
– ident: 10.1186/1750-2187-8-3-B35
  doi: 10.1016/S0960-9822(02)01034-5
– ident: 10.1186/1750-2187-8-3-B41
  doi: 10.1016/S0955-0674(96)80065-2
– ident: 10.1186/1750-2187-8-3-B43
  doi: 10.1074/jbc.M410594200
– ident: 10.1186/1750-2187-8-3-B8
  doi: 10.1083/jcb.200501104
– ident: 10.1186/1750-2187-8-3-B32
  doi: 10.1038/334712a0
– ident: 10.1186/1750-2187-8-3-B38
  doi: 10.1126/science.275.5299.533
– ident: 10.1186/1750-2187-8-3-B36
  doi: 10.1074/jbc.C400508200
– ident: 10.1186/1750-2187-8-3-B28
  doi: 10.1128/MCB.21.22.7775-7786.2001
– ident: 10.1186/1750-2187-8-3-B25
  doi: 10.1074/jbc.270.4.1734
– ident: 10.1186/1750-2187-8-3-B1
  doi: 10.1016/j.tips.2008.08.002
– ident: 10.1186/1750-2187-8-3-B30
  doi: 10.1016/j.cellsig.2010.09.005
– ident: 10.1186/1750-2187-8-3-B20
  doi: 10.1038/nsmb888
– ident: 10.1186/1750-2187-8-3-B26
  doi: 10.1073/pnas.82.16.5255
– ident: 10.1186/1750-2187-8-3-B17
  doi: 10.1126/science.280.5372.2109
– ident: 10.1186/1750-2187-8-3-B19
  doi: 10.1074/jbc.M301409200
– ident: 10.1186/1750-2187-8-3-B46
  doi: 10.1074/jbc.M001863200
– ident: 10.1186/1750-2187-8-3-B22
  doi: 10.1021/bi051729t
– ident: 10.1186/1750-2187-8-3-B11
  doi: 10.1074/jbc.274.9.5868
– ident: 10.1186/1750-2187-8-3-B29
  doi: 10.1124/mol.106.033555
– ident: 10.1186/1750-2187-8-3-B6
  doi: 10.1016/S0092-8674(00)80482-1
– ident: 10.1186/1750-2187-8-3-B42
  doi: 10.1016/j.cellsig.2007.03.004
– ident: 10.1186/1750-2187-8-3-B12
  doi: 10.1016/S0014-5793(00)02224-9
– ident: 10.1186/1750-2187-8-3-B45
  doi: 10.1111/j.1476-5381.2009.00180.x
– ident: 10.1186/1750-2187-8-3-B13
  doi: 10.1073/pnas.0234057100
– ident: 10.1186/1750-2187-8-3-B9
  doi: 10.1073/pnas.0510254103
– ident: 10.1186/1750-2187-8-3-B21
  doi: 10.1074/jbc.M110.201392
– ident: 10.1186/1750-2187-8-3-B40
  doi: 10.1038/ncb2507
– ident: 10.1186/1750-2187-8-3-B23
  doi: 10.1073/pnas.94.19.10098
– ident: 10.1186/1750-2187-8-3-B39
  doi: 10.1073/pnas.102291599
– ident: 10.1186/1750-2187-8-3-B24
  doi: 10.1074/jbc.M007608200
– ident: 10.1186/1750-2187-8-3-B27
  doi: 10.1101/gad.12.1.95
– ident: 10.1186/1750-2187-8-3-B3
  doi: 10.1021/bi700235f
– ident: 10.1186/1750-2187-8-3-B7
  doi: 10.1073/pnas.2533143100
SSID ssj0053546
Score 2.0071266
Snippet Heterotrimeric guanine nucleotide binding proteins of the G12/13 subfamily, which includes the α-subunits Gα12 and Gα13, stimulate the monomeric G protein RhoA...
BACKGROUNDHeterotrimeric guanine nucleotide binding proteins of the G12/13 subfamily, which includes the α-subunits Gα12 and Gα13, stimulate the monomeric G...
BACKGROUND: Heterotrimeric guanine nucleotide binding proteins of the G12/13 subfamily, which includes the α-subunits Gα12 and Gα13, stimulate the monomeric G...
SourceID pubmedcentral
biomedcentral
proquest
crossref
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 3
SummonAdditionalLinks – databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1LS8QwEA66XryIuj7WFxHEW7Rt2qQ9iIivRXAP4sLeQtImKKytrhXcn-Uf8Tc5SberXfWcSSn5Mp1v0m8mCB1QnillIkN86msSSsNIkvmUQCyIeSYNZ8apLXqs2w9vBtHgu6XQZAFf_0zt7H1S_dHw6P1lfAoOf-IcPmbHEAE9AqEKPreEzqOFAIKiVXfdhtMfChGtanampnW7zdnptjkwhX0ZWOFhowR-2Ixcv-jorKryR5i6WkZLE36Jz6oNsYLmdL6K2mc55NZPY3yIneLTHaW3kbj4oYXBssRABnGPYJln-JxUQ4-4MPj688MP8Ehb1bDOMPBcbOshqtNca3D3UBBXgwL8FVtJiLRV7muof3V5f94lkwsXiKKBVxIdcfgOZ16Qaq4poMsZZ6H2JJPaz0LI_biktkN-FivgKVJpAyaxp-KQcuBFdB218iLXmwjrgKZJaljgpSZUkGOl1KTAxVIVGV8ntIOSxuKK56q5hrDtrpsj4HnCYiQsRiIWMPewBmI6zeUyMZs13K9hEuA19leIzHXx9ip8GrKI8yQGm40Ktumjavw7iDcAbbxicyR_fHCduantvsaTrX-fuY0WA3efBnhDtINa5ehN7wKrKdWe269f3rn1MA
  priority: 102
  providerName: Scholars Portal
Title Determinants at the N- and C-termini of Gα12 required for activation of Rho-mediated signaling
URI https://www.ncbi.nlm.nih.gov/pubmed/23531275
https://search.proquest.com/docview/1346577983
http://dx.doi.org/10.1186/1750-2187-8-3
https://pubmed.ncbi.nlm.nih.gov/PMC3636079
Volume 8
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS-wwFA4-Nm4uvq7Xqw4RxF2ctnl2qeMLwUHkCrMLSZrggNMR77jwZ_lH_E2epFOxunNZkpTQ7yTnO-l3ThA6oLKyNvBAcpp7wkwQpKxySsAXKFmZIEVIaouhuLxjVyM-WkC8zYVJon1nx0f1w-SoHt8nbeXjxPVbnVj_5npAY5ErWfYX0SK43zZEb7ZfTjkTbTFNJfrgHjMCfgz2YhIvzSkoWF0RZYWdBPeHrl_6Rja_aiY_OaHzVfRrzh7xcTPLNbTg63W0cVxD5Dx5wYc46TnTQfkG0qeflC7YzDBQPTwk2NQVHpCmaYynAV-8veYFfvJRE-wrDCwWx2yH5qw2dri9n5KUYQLsFEfBh4k57Jvo7vzs3-CSzK9TIJYW2Yx4LmGXrbLCeekpYCeFFMxnRhifVwwiO2lorH9fKQssxFgfoIvKrGJUAuuhv9FSPa39H4R9QV3pgigyF5iFCMrR4IBpOctD7ku6jcrOx9WPTekMHYtZd1tgXemIkY4YaaVh7GELxMewFKko8bXjfguThjURf3SY2k-f_-ucMsGlLBX02Wpg-3hVi_82kh1AO1PstoAZprrbc7P7--ORO2ilSLdpwFrgu2hp9vTs94DTzGwPLHkke2j55Gx4cwtP10z1kl2_A7Ff_eo
link.rule.ids 230,314,727,780,784,885,2221,24318,27924,27925,31720,33745,53791,53793
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JTsMwELVYDnBB7DsYCXEzTeLYTo6oLGWrEAKJm2U7tqhEU1TaA5_Fj_BNjJ0GEbhx9jiy8saeN8mbMUKHVBRaO-ZITGNLUuU4yYuYEogFmSiUE9wFtUWXdx7Tqyf2NIVYXQsTRPtG947Ll_5x2XsO2srXvmnVOrHW3W2b-iZXIm9No1lGRR7XSXp1ADPKUl6308x4CwJkRCCSwWlM_LU5CQW_S7ywsFHi_tKMTH_o5m_V5I8wdL6IFib8EZ9U61xCU7ZcRisnJeTO_Xd8hIOiM3wqX0Hy9IfWBasRBrKHuwSrssBtUg318MDhi8-POMFD61XBtsDAY7Gvd6i-1nqD--cBCTUmwE-xl3woX8W-ih7Pzx7aHTK5UIFomkQjYpmAc7aIEmOFpYCe4IKnNlJc2bhIIbcTivoO-EWmgYcobR2YZJHOUiqA99A1NFMOSruBsE2oyY3jSWRcqiGHMtQZ4FpGMxfbnG6ivPFy5WvVPEP6dtbNEdhZ0mMkPUYykzD3qAbie1rIVTL-2_CghknCrvC_OlRpB-M3GdOUMyHyDGzWK9i-H1Xjv4lEA9DGEpsj4Iih8_bE8bb-PXMfzXUebm_kzWX3ehvNJ-FuDdgZbAfNjIZjuwsMZ6T3gj9_AUyp_eQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwELZ4SIhLVd60BYyEuJk8HNvJES1d3iuEQOJm-SlWYrMruhz6s_pH-ps6djZoQ2-cPY6sfGPPN8k3Y4SOqLBae-ZJRjNHCuU5qWxGCcSCUljlBfdRbTHgF4_F1RN7mrvqK4r2jR6e1C-jk3r4HLWVk5FJWp1Ycnfbo6HJlaiSifXJIlpmFJysTdSbQ5hRVvC2pWbJEwiSKYFoBicyCVfn5BR8Lw_iwk6Z-0s3Ov1HOT8qJ-dCUf8r-jLjkPi0WesaWnD1Oto4rSF_Hv3GxziqOuPn8g0kz-b0LlhNMRA-PCBY1Rb3SDM0xGOPz__-yXL86oIy2FkMXBaHmofmi20wuH8ek1hnAhwVB9mHCpXsm-ix__Ohd0FmlyoQTfN0ShwTcNbaNDdOOAoICi544VLFlctsAfmdUDR0wbelBi6itPNgUqa6LKgA7kO30FI9rt0Owi6npjKe56nxhYY8ylBvgG8ZzXzmKrqLqs7LlZOmgYYMLa27I7C7ZMBIBoxkKWHucQvE-7SYr5T8o-FhC5OEnRF-d6jajd9-yYwWnAlRlWCz3cD2_qgW_10kOoB2ltgdAWeM3bdnzvft0zMP0MrdWV_eXA6uv6PVPF6vAZuD_UBL09c3twckZ6r3ozv_A-Si_vc
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Determinants+at+the+N-+and+C-termini+of+G%CE%B112+required+for+activation+of+Rho-mediated+signaling&rft.jtitle=Journal+of+molecular+signaling&rft.au=Ritchie%2C+Benjamin+J&rft.au=Smolski%2C+William+C&rft.au=Montgomery%2C+Ellyn+R&rft.au=Fisher%2C+Elizabeth+S&rft.date=2013-03-25&rft.issn=1750-2187&rft.eissn=1750-2187&rft.volume=8&rft.issue=1&rft.spage=3&rft_id=info:doi/10.1186%2F1750-2187-8-3&rft_id=info%3Apmid%2F23531275&rft.externalDocID=23531275
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1750-2187&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1750-2187&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1750-2187&client=summon